<DOC>
	<DOC>NCT01537614</DOC>
	<brief_summary>Pharmacokinetics of colimycin will be assessed during 12 hours after administration of 2M UI colimycin either as an aerosol or after IV injection, the administration being separated by 5 to 10 days intervals</brief_summary>
	<brief_title>Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Males and females, adults. Suffering from stable cystic fibrosis Colonized by P. aeruginosa Having given informed consent. Able to follow the protocol Having a social insurance Renal insufficiency Allergy to colistin or polymixins Myasthenia Recent severe hemoptysis Liver cirrhosis and hepatic insufficiency Hypoalbuminemia Colonization by Burkholderia cepaea or Stenotrophomonas maltophilin Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>